Skip to main content
. 2012 Sep 12;2012(9):CD007146. doi: 10.1002/14651858.CD007146.pub3

Comparison 10. Medication provision: other medications vs control.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
10.1 Rate of falls 1   Rate Ratio (IV, Fixed, 95% CI) Subtotals only
10.1.1 Hormone replacement therapy vs placebo 1 212 Rate Ratio (IV, Fixed, 95% CI) 0.88 [0.65, 1.18]
10.1.2 Hormone replacement therapy + calcitriol vs placebo 1 214 Rate Ratio (IV, Fixed, 95% CI) 0.75 [0.58, 0.97]
10.2 Number of fallers 3   Risk Ratio (IV, Fixed, 95% CI) Subtotals only
10.2.1 Hormone replacement therapy vs control/placebo 2 585 Risk Ratio (IV, Fixed, 95% CI) 0.94 [0.81, 1.08]
10.2.2 Hormone replacement therapy + calcitriol vs placebo 1 214 Risk Ratio (IV, Fixed, 95% CI) 0.90 [0.72, 1.11]
10.2.3 Alendronate + vitamin D3 vs control 1 515 Risk Ratio (IV, Fixed, 95% CI) 0.82 [0.59, 1.14]
10.3 Number of people sustaining a fracture 1   Risk Ratio (IV, Fixed, 95% CI) Subtotals only
10.3.1 Calcium vs placebo 1 1255 Risk Ratio (IV, Fixed, 95% CI) 0.90 [0.69, 1.16]
10.3.2 Vitamin K2 + vitamin D2 + calcium vs control (Alzheimer's disease) 0 0 Risk Ratio (IV, Fixed, 95% CI) Not estimable
HHS Vulnerability Disclosure